Skip to main content
Clinical Trials/NCT00914407
NCT00914407
Completed
Not Applicable

Measurement of Retinal Blood Flow, Retinal Oxygenation and Retinal Oxygen Extraction in Healthy Subjects During Normoxia and Systemic Hyperoxia

Medical University of Vienna1 site in 1 country48 target enrollmentApril 2010

Overview

Phase
Not Applicable
Intervention
Oxygen
Conditions
Healthy
Sponsor
Medical University of Vienna
Enrollment
48
Locations
1
Primary Endpoint
Retinal blood velocity Retinal vessel diameters Oxygen saturation of retinal vessels Oxygen extraction as calculated from these parameters
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The inner retina is crucially dependent on an adequate retinal blood supply. When the retina becomes ischemic and hypoxic this results in severe vision loss due to retinal neovascularization. Measurement of retinal blood flow and retinal oxygenation is, however, still a difficult task. Information on retinal oxygenation is almost unavailable from human studies. In the present protocol the investigators propose a procedure allowing for the measurement of retinal blood flow, retinal oxygenation and retinal oxygen extraction by combining a number of innovative techniques. Specifically, retinal vessel diameters will be measured with a Retinal Vessel Analyzer, retinal blood velocities with bi-directional laser Doppler velocimetry and retinal oxygenation with spectroscopic evaluation of retinal fundus images. This will allow for the calculation of retinal oxygen extraction, a fundamental parameter of retinal function. Up to now, no data for retinal oxygen extraction are available in the literature.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
March 1, 2017
Last Updated
9 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gerhard Garhofer

Assoc. Prof. Priv.-Doz. Dr

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Men and women aged between 18 and 35 years
  • Nonsmokers
  • Body mass index between 15th and 85th percentile
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
  • Normal laboratory values unless the investigator considers an abnormality to be clinically irrelevant
  • Normal ophthalmic findings, ametropia \< 3 Dpt

Exclusion Criteria

  • Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
  • Treatment in the previous 3 weeks with any drug except oral contraceptives
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Blood donation during the previous 3 weeks
  • Pregnancy

Arms & Interventions

Healthy subjects

Intervention: Oxygen

Outcomes

Primary Outcomes

Retinal blood velocity Retinal vessel diameters Oxygen saturation of retinal vessels Oxygen extraction as calculated from these parameters

Time Frame: 20 min ocular blood flow measurement on 1 study day

Study Sites (1)

Loading locations...

Similar Trials